AO: The analyst looks at the values of serving the “public good” that were fulfilled through the development of HPV vaccines by US government scientists.
AO: The analyst noted the importance of collaboration because of need for interdisciplinary knowledges to tackle the problem: “Schiller and Lowy’s absence of formal training in either vaccinology or clinical trial design, and the NCI’s lack of experience in producing biologicals, created barriers that necessitated collaboration outside of their laboratory” (9).
